Nov 8, 2022 02:00 PM in Eastern Time (US and Canada)
Topic: e-PANDAS Webinar - Ask an Author: Key Changes in the Newly Revised ASHP Guidelines on Preventing Diversion of Controlled Substances
Description: ASHP recently revised the ASHP Guidelines on Preventing Diversion of Controlled Substances. Last published in 2016, the guidelines encourage healthcare organizations to develop a collaborative, comprehensive controlled substance diversion prevention program (CSDPP) that complies with applicable federal and state laws and regulations; supports rigorous monitoring and surveillance, human resource management, and substance abuse treatment programs; and establishes systems to positively influence prescribing, procurement, dispensing, administration, and proper disposal and wasting of controlled substances. This webinar will outline recent events involving the DEA, the CSDPP framework and strategies for operation, and summarize key changes in the revised guidelines.